Seizert Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-21,350
Closed -$1.22M 191
2021
Q2
$1.22M Buy
21,350
+1,873
+10% +$109K 0.06% 128
2021
Q1
$1.18M Buy
19,477
+1,566
+9% +$86.4K 0.06% 128
2020
Q4
$959K Sell
17,911
-327
-2% -$17K 0.06% 130
2020
Q3
$856K Sell
18,238
-1,625
-8% -$83.4K 0.06% 126
2020
Q2
$1.04M Sell
19,863
-3,396
-15% -$175K 0.07% 110
2020
Q1
$1.11M Sell
23,259
-6,206
-21% -$322K 0.08% 100
2019
Q4
$1.49M Hold
29,465
0.07% 108
2019
Q3
$1.39M Hold
29,465
0.07% 109
2019
Q2
$1.39M Buy
29,465
+7,307
+33% +$337K 0.07% 110
2019
Q1
$1.07M Buy
+22,158
New +$1.11M 0.05% 133

Other funds holding CAH

Seizert Capital Partners's CAH Position: Q3 2021 in Review

Seizert Capital Partners sold out of Cardinal Health (CAH) in Q3 2021, closing a stake of 21,350 shares — an estimated $1.22M sold.

Seizert Capital Partners first reported a position in CAH in Q1 2019 and held it in 10 quarters. The position peaked at $1.49M in Q4 2019. 748 funds tracked by Wall St. Rank hold CAH as of Q3 2021.

  • Seizert Capital Partners reported no remaining Cardinal Health position as of Q3 2021 after selling out during the quarter.
  • Seizert Capital Partners sold 21,350 Cardinal Health shares in Q3 2021, an estimated $1.22M.
  • Seizert Capital Partners first reported a position in Cardinal Health in Q1 2019 and held it in 10 quarters.
  • Seizert Capital Partners's Cardinal Health position peaked at $1.49M in Q4 2019.
  • 748 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2021.

Based on Seizert Capital Partners's 13F filing for Q3 2021, filed 3 Nov 2021.